Identifying agents to prevent cancer in high-risk individuals
CAP-IT CRI U54 ADMINISTRATIVE CORE
This study is looking for new ways to help people at higher risk of cancer by testing special treatments, like RNA vaccines, that could prevent the disease, while also making it easier for researchers to work together on this important goal.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10906210 on NIH RePORTER |
What this research studies
This research focuses on finding and validating immunologically targeted agents that can help prevent cancer in individuals who are at an increased risk. The project aims to streamline administrative processes to enhance collaboration among various research teams and ensure that the scientific work remains focused on its primary goal. By integrating genomic databases and cutting-edge technologies, the research seeks to develop innovative prevention strategies, including RNA vaccines. Patients may benefit from advancements in personalized cancer prevention approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals identified as having an increased risk of cancer due to genetic or environmental factors.
Not a fit: Patients who are not at increased risk for cancer or those with existing cancer diagnoses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments for individuals at high risk of developing cancer.
How similar studies have performed: Other research has shown promise in using immunologically targeted agents for cancer prevention, indicating a potential for success in this approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Lipkin, Steven M — Weill Medical Coll of Cornell Univ
- Study coordinator: Lipkin, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.